Rated by clients as being ‘in a league of its own’, Setterwalls maintains its stellar reputation for handling the full spectrum of mandates for diagnostic companies, drug distributors, and medical device clients. The group exhibits broad expertise in M&A, licensing and supply agreements, and disputes concerning generics and biosimilars. Leading the practice out of the Malmö office, Per Lidman is known for his longstanding IP expertise, regularly acting for pharma and medtech clients in patent disputes. Martin Levinsohn maintains an IP and competition-focused practice, with his caseload including market exclusivity and marketing-related issues within life sciences. Regulatory specialist Helena Nilsson is well-versed in mandates involving clinical studies, and classification and distribution issues.
Testimonials
Collated independently by Legal 500 research team.
‘They have a broad team with knowledge about the pharmaceutical market in Sweden.’
‘Martin Levihnson has deep knowledge and understanding of the pharma sector in Sweden. He is analytical and very skilled in presenting a case.’
‘Setterwalls has the unique ability to provide a team where all individuals have special but still overlapping competences. Their internal cooperation is immaculate and everyone had very high work ethics and competence. Setterwalls are not comparable with the other firms, but are in a league of their own.’
‘Helena Nilsson has a strong profile with broad experience in the regulatory authority side, which has been hugely helpful to us in connection with several authority discussions, both in relation to the reimbursement agency and the medicines product agency.’
‘Setterwalls has been an excellent legal adviser in the healthcare and life sciences sector, providing top-tier advice on complex contractual issues.’
‘Very strong subject matter skills. Very knowledgeable team and very hard working and committed. Always delivered on time and went the extra mile to make sure that agreements were as optimal as possible both from a legal and commercial perspective.’
‘Richard Hammarvid was very knowledgeable with a strong contact network with other law firms.’
- ‘Hanna Sonning has a good interdisciplinary background with strong knowledge about the life science sector.’
Key clients
- Abacus Medicine
- Accord Healthcare
- Apoteksgruppen i Borrby nr 1 AB
- Barry Callebaut
- Blodtrycksdoktorn
- Cloetta
- Coala Life
- Doktorse Nordic
- EQL Pharma
- Fresenius Kabi
- Gnosco AB
- Gutfeeling Labs
- Index Pharmaceuticals
- Isofol Medical AB
- Move & Walk Sverige AB
- Mylan/Viatris
- Neuraxpharm
- Nordic Trading Group
- Novo Nordisk
- Orifarm
- Respiratorius
- Sandoz
- Sever Pharma Solutions
- Zentiva
Work highlights
- Representing Nordic Trading Group B.V. against the Medical Products Agency (MPA) in the Supreme Administrative Court against the MPA’s decision to prohibit online sales of cannabidiol products to consumers in Sweden.
- Representing Sandoz in a patent dispute with Bayer concerning Bayer’s patent for a once-daily dosing regimen for the active ingredient rivaroxaban, which is a pharmaceutical used in the prevention and treatment of thromboembolism.
- Representing Neuraxpharm, a Spanish supplier of generic medicines, in a patent dispute against Biogen concerning Biogen’s patent for a specific dose of the active ingredient dimethylfumarate, which is used in the treatment of MS.
Lawyers
Practice head
The lawyer(s) leading their teams.
Per Lidman